Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history. The footer items 'HHS Vulnerability Disclosure' and the prior 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry v3.3.2 was added to the study record history and the previous revision v3.2.0 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedNotice about government funding lapse and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check62 days agoChange DetectedRecord History shows updates to Study Status on 2022-02-10 and Recruitment Status on 2024-03-11 for NCT05116475.SummaryDifference0.1%

- Check91 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference13%

- Check98 days agoChange DetectedUpdate to a newer software version label: from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.